Selvita S.A. Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Selvita S.A.
Access all reports
Selvita S.A. is active in the pharmaceutical and biotechnology sectors. The company specializes in providing integrated services that encompass a wide range of solutions to support drug discovery, regulatory studies, and research and development. Selvita offers comprehensive drug discovery support from the initial stages of target validation through to the preclinical research phase, including the development and validation of drug testing and bioanalytical methods. The organization works closely with various research institutes and universities primarily in Europe and the United States. Founded in 2007, Selvita employs a large team of professionals, including a significant proportion with PhD qualifications. The company is headquartered in Krakow, Poland, and its shares are listed on the Warsaw Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SLV
Country
🇵🇱 Poland